Expanding its Diagnostics Business footprint in East India
Ranchi, India, July 19, 2022: Global pharma major Lupin Limited (Lupin) announced today that Lupin Diagnostics has launched its first Reference Laboratory in Ranchi. The new Reference Laboratory at Ranchi is equipped to conduct a broad spectrum of routine and specialized tests in the fields of molecular diagnostics, cytogenetics, flow cytometry, histopathology, cytology, microbiology, serology, haematology, immunology, and routine biochemistry.
Lupin Diagnostics will equip doctors with accurate diagnosis in the patient journey by leveraging innovative technologies for improved patient care. People in Jharkhand can now avail preventive health check-ups, home collection and testing centers at 10 locations.
Ravindra Kumar, Vice President and Head – Lupin Diagnostics said, “We are thrilled to expand our diagnostics services that includes extensive range of tests and curated health check packages to Jharkhand market. The launch of our Reference Laboratory in Ranchi is a step forward to provide high-standard diagnostics to enable doctors to diagnose patient health accurately, make safer interventions and overall, improve patient outcomes.”
“As part of Lupin Diagnostics’ services, patients can collect samples at home free of charge and keep track of them in real-time. Our personalized and interactive smart reports allow patients and doctors to gain insight into historical trends in health parameters, assisting doctors in making evidence-based treatment decisions,” he added.
In order to serve East India comprehensively, Lupin Diagnostics has established a reference laboratory in Ranchi, Jharkhand following the establishment of processing laboratories in Assam, West Bengal, and Bihar. Currently, Lupin Diagnostics has over 100 LupiMitra (Lupin’s franchise collection centers) already enrolled for its East India operations.
Lupin Diagnostics provides a comprehensive range of diagnostic services to doctors, patients and consumers. Some of its key consumer-centric features are GPS-enabled temperature-controlled sample movement, smart reports, NABL accreditation of each laboratory, trend report analysis, and live home collection booking and tracking. The company started its journey by establishing a state- of-the-art 45,000 square foot National Reference Laboratory in Navi Mumbai with world-class equipment, experienced doctors assisted by trained technologists and stringent quality control protocols.
Lupin is an innovation-led transnational pharmaceutical company headquartered in Mumbai, India. The Company develops and commercializes a wide range of branded and generic formulations, biotechnology products, and APIs in over 100 markets in the U.S., India, South Africa, and across the Asia Pacific (APAC), Latin America (LATAM), Europe, and Middle East regions.
The Company enjoys a leadership position in the cardiovascular, anti-diabetic, and respiratory segments and has a significant presence in the anti-infective, gastro-intestinal (GI), central nervous system (CNS), and women’s health areas. Lupin is the third-largest pharmaceutical company in the U.S. by prescriptions. The company invested 8.7% of its revenue in research and development in FY22.
Lupin has 15 manufacturing sites, 7 research centres, more than 20,000 professionals working globally, and has been consistently recognized as a ‘Great Place to Work’ in the Biotechnology & Pharmaceuticals sector.
Please visit www.lupin.com for more information.
About Lupin Diagnostics
Lupin Diagnostics is a part of Lupin Healthcare Limited, which is a wholly owned subsidiary of Lupin Limited. Founded in October 2021, the company is headquartered in Mumbai, India and provides comprehensive range of diagnostic services to doctors, patients and consumers.
The company began its journey by establishing a state- of-the-art 45,000 sq. ft. National Reference Laboratory located in Navi Mumbai with world-class equipment, experienced doctors assisted by trained technologists and stringent quality control protocols. Over 2,500 tests including routine and high-end tests are offered under Pathology (molecular diagnostics, cytology, microbiology, serology, hematology, immunology, and routine biochemistry).
Currently, the company’s network consists of 18 Labs, close to 280 exclusive collection centers (LupiMitra), and over 450 pick-up points.
Experience the best diagnostic experiences with Lupin Diagnostics – https://www.lupindiagnostics.com/
Follow us on Facebook: https://www.facebook.com/lupindiagnostics
For further information or queries please contact –
Vice President & Global Head – Corporate Communications